Data show hemophilia bleeds can be successfully treated while on Hympavzi
WHY IT MATTERS
If you have hemophilia, this news shows that Hympavzi can reduce bleeding episodes while still allowing doctors to treat any bleeds that do happen with familiar, proven treatments—meaning you don't have to choose between prevention and effective emergency care.
Hympavzi is a new injection medicine approved in 2024 to help prevent bleeding in people with hemophilia. In the large study that led to its approval, the medicine worked well at stopping bleeds before they happened. When breakthrough bleeds did occur, doctors were able to treat them successfully using standard blood clotting medicines.
In the large clinical trial that supported the 2024 approval of Hympavzi (marstacimab) for adults and children with hemophilia, use of the prophylactic injection therapy was found to help prevent bleeding episodes. Breakthrough bleeds that did occur, or minor surgical procedures that were needed, were generally effectively treated with standard clotting factor replacement therapy without […] The post Data show hemophilia bleeds can be successfully treated while on Hympavzi appeared first o
ASK YOUR DOCTOR
Ask your hemophilia care team at your next appointment whether Hympavzi might be appropriate for you and what the process would be to access it.